# Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma

> **NCT06190457** · — · COMPLETED · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 16 (actual)

## Conditions studied

- Lymphoma, Non-Hodgkin
- Child, Only

## Interventions

- **OTHER:** intrathecal rituximab

## Key facts

- **NCT ID:** NCT06190457
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-30
- **Primary completion:** 2020-12-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06190457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06190457, "Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06190457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*